![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of human disease. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for ... Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of human disease. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes. Show more
THE WOODLANDS, Texas, July 08, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the Lexicon Board of Directors has appointed Mike Exton, Ph.D. as chief...
Lexicon Seeks Approval for Sotagliflozin as an Adjunct to Insulin Therapy for Glycemic Control in People with Type 1 Diabetes and Chronic Kidney Disease Company Anticipates Six Month Review and...
Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people with diabetic peripheral neuropathic pain (DPNP...
New analysis of the pivotal Phase 3 SOLOIST-WHF trial demonstrates INPEFA cost-effectiveness Findings consistent with another study recently published in the Journal of Comparative Effectiveness...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.07 | -4.16666666667 | 1.68 | 1.765 | 1.58 | 1641903 | 1.64987011 | CS |
4 | -0.12 | -6.93641618497 | 1.73 | 2.03 | 1.58 | 2569919 | 1.7718421 | CS |
12 | -0.34 | -17.4358974359 | 1.95 | 2.04 | 1.48 | 2654231 | 1.72971427 | CS |
26 | 0.11 | 7.33333333333 | 1.5 | 3.73 | 1.24 | 3667625 | 2.15920649 | CS |
52 | -0.72 | -30.9012875536 | 2.33 | 3.73 | 0.92 | 2909796 | 1.86761222 | CS |
156 | -2.16 | -57.2944297082 | 3.77 | 6.3299 | 0.92 | 1612108 | 2.31508245 | CS |
260 | -4.69 | -74.4444444444 | 6.3 | 9.65 | 0.92 | 2002625 | 3.13713239 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions